Who Supplies Carvedilol? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Carvedilol exports, with 242+ registered manufacturers shipping to buyers across 98+ countries — yet a handful of companies dominate the shipments. ZYDUS LIFESCIENCES LIMITED holds the largest share at 20.1% (export value: $19.7M). Close behind, CARITAS HEALTHCARE PRIVATE LIMITED (16.2%, $15.8M). CIPLA LIMITED (6.9%, $6.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Carvedilol? Top Manufacturers & Their Buyers
Flow of Carvedilol from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Carvedilol Supplier Network — Key Market Intelligence
The Carvedilol export market from India is led by ZYDUS LIFESCIENCES LIMITED, which alone commands a 20.1% share, shipping $19.7M worth of product across 656 shipments. The second-largest exporter, CARITAS HEALTHCARE PRIVATE LIMITED, contributes $15.8M (16.2%) to the overall market. Combined, the top two suppliers alone account for 36.2% of all Carvedilol exports, indicating a relatively concentrated supply base.
Across all 242 tracked manufacturers, the total Carvedilol export value stands at $98.1M from 4.8K shipments. The market average shipment value is $20.6K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCE SERVICES LLC, receiving $15.6M worth of product.
The combined buyer network spans 17 named purchasing companies, including EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH, PRIORITY HEALTHCARE DISTRIBUTION, SUNSHINE HEALTHCARE , TO THE PURCHASE MANAGER and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the first-largest Carvedilol exporter from India, with a market share of 20.1% and a total export value of $19.7M across 656 shipments. Their average shipment value of $30.0K is above the market average of $20.6K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 79.4% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $15.6M across 521 shipments (79.4% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH — $2.9M across 96 shipments (14.6% of this supplier's total exports)
• PRIORITY HEALTHCARE DISTRIBUTION — $719.2K across 24 shipments (3.7% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH — $258.3K across 9 shipments (1.3% of this supplier's total exports)
• SUNSHINE HEALTHCARE — $208.3K across 7 shipments (1.1% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $30.0K is 45% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.
2CARITAS HEALTHCARE PRIVATE LIMITED
CARITAS HEALTHCARE PRIVATE LIMITED is the second-largest Carvedilol exporter from India, with a market share of 16.2% and a total export value of $15.8M across 29 shipments. Their average shipment value of $546.5K is above the market average of $20.6K, suggesting premium or bulk contract pricing.
CARITAS HEALTHCARE PRIVATE LIMITED serves 4 named buyers in our database. TO THE PURCHASE MANAGER is the dominant customer, accounting for 96.4% of this supplier's tracked business. Top customers include:
• TO THE PURCHASE MANAGER — $15.3M across 28 shipments (96.4% of this supplier's total exports)
• F.D.E.C.A — $370.1K across 1 shipments (2.3% of this supplier's total exports)
• FDECA QUITO ECUADOR — $160.5K across 0 shipments (1.0% of this supplier's total exports)
• F.D.E.C.A — $47.4K across 0 shipments (0.3% of this supplier's total exports)
Key Insight: CARITAS HEALTHCARE PRIVATE LIMITED's per-shipment value of $546.5K is 2547% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.
3CIPLA LIMITED
CIPLA LIMITED is the third-largest Carvedilol exporter from India, with a market share of 6.9% and a total export value of $6.8M across 28 shipments. Their average shipment value of $243.1K is above the market average of $20.6K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:
• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $6.6M across 27 shipments (97.5% of this supplier's total exports)
• PROFON S A — $64.9K across 0 shipments (1.0% of this supplier's total exports)
• MEDICA PHARMACEUTICA — $40.6K across 0 shipments (0.6% of this supplier's total exports)
• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $35.6K across 0 shipments (0.5% of this supplier's total exports)
• PROFON S A — $31.2K across 0 shipments (0.5% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $243.1K is 1078% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.
4PIRAMAL PHARMA LIMITED
PIRAMAL PHARMA LIMITED is the fourth-largest Carvedilol exporter from India, with a market share of 6.5% and a total export value of $6.4M across 141 shipments. Their average shipment value of $45.4K is above the market average of $20.6K, suggesting premium or bulk contract pricing.
PIRAMAL PHARMA LIMITED serves 3 named buyers in our database. TEVA PHARMACEUTICALS USA INC is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:
• TEVA PHARMACEUTICALS USA INC — $4.1M across 91 shipments (64.8% of this supplier's total exports)
• TEVA PHARMACEUTICALS USA INC — $1.8M across 40 shipments (28.7% of this supplier's total exports)
• TEVA PHARMACEUTICALS USA INC — $416.4K across 9 shipments (6.5% of this supplier's total exports)
Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $45.4K is 120% above the market average of $20.6K, consistent with large-order contracts or value-added formulations.
5GLENMARK PHARMACEUTICALS LIMITED
GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Carvedilol exporter from India, with a market share of 5.1% and a total export value of $5.0M across 257 shipments. Their average shipment value of $19.3K is below the market average of $20.6K, reflecting a high-volume, competitive pricing strategy.
GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. GLENMARK PHARMACEUTICALS INC is the dominant customer, accounting for 57.6% of this supplier's tracked business. Top customers include:
• GLENMARK PHARMACEUTICALS INC — $2.9M across 148 shipments (57.6% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $825.9K across 43 shipments (16.7% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $737.0K across 38 shipments (14.9% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $311.1K across 16 shipments (6.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS INC — $226.3K across 12 shipments (4.6% of this supplier's total exports)
Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (257 shipments) at a per-shipment value of $19.3K, indicating a broad distribution network with many smaller, regular orders.
6AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Carvedilol exporter from India, with a market share of 1.5% and a total export value of $1.5M across 484 shipments. Their average shipment value of $3.0K is below the market average of $20.6K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• APL SWIFT SERVICES (MALTA) LTD., — $580.4K across 192 shipments (39.6% of this supplier's total exports)
• SIVEM PHARMACEUTICAL — $374.2K across 124 shipments (25.5% of this supplier's total exports)
• DIFEM LABORATORIOS S.A, — $200.6K across 66 shipments (13.7% of this supplier's total exports)
• MILPHARM LIMITED — $199.6K across 66 shipments (13.6% of this supplier's total exports)
• AURO PHARMA INC, — $111.4K across 37 shipments (7.6% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (484 shipments) at a per-shipment value of $3.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Carvedilol Flows
Once Carvedilol leaves the manufacturing plants of companies like ZYDUS LIFESCIENCES LIMITED and CARITAS HEALTHCARE PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $98.1M. United States absorbs the largest share at 60.1% ($59.0M), followed by Ecuador (16.5%) and Yemen (6.9%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, TEVA PHARMACEUTICALS USA, INC, GLENMARK PHARMACEUTICALS INC., USA. In Ecuador, key buyers are TO THE PURCHASE MANAGER.
This geographic spread reflects Carvedilol's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Carvedilol Go? Top Importing Countries & Their Buyers
Trade flow of Carvedilol exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Carvedilol imports from India, with a total trade value of $59.0M across 1,408 shipments — representing a 60.1% share of all Carvedilol exports. The average shipment value of $41.9K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 15 tracked buyers.
Named Carvedilol importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 32.7% ($19.3M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $19.3M (32.7% of United States's total)
• TEVA PHARMACEUTICALS USA, INC — $6.5M (11.1% of United States's total)
• GLENMARK PHARMACEUTICALS INC., USA — $6.3M (10.6% of United States's total)
Key Insight: United States's per-shipment average of $41.9K (103% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Carvedilol imports from India.
2Ecuador
Ecuador ranks as the second-largest destination for Carvedilol imports from India, with a total trade value of $16.2M across 10 shipments — representing a 16.5% share of all Carvedilol exports. The average shipment value of $1.6M is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carvedilol importers in Ecuador: TO THE PURCHASE MANAGER is the largest buyer, accounting for 95.5% ($15.5M) of this market's total imports.
• TO THE PURCHASE MANAGER — $15.5M (95.5% of Ecuador's total)
Key Insight: Ecuador's per-shipment average of $1.6M (7747% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ecuador is a key market for Carvedilol imports from India.
3Yemen
Yemen ranks as the third-largest destination for Carvedilol imports from India, with a total trade value of $6.7M across 10 shipments — representing a 6.9% share of all Carvedilol exports. The average shipment value of $672.6K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carvedilol importers in Yemen: CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the largest buyer, accounting for 98.6% ($6.6M) of this market's total imports.
• CIPLAMEDICA PHARMACEUTICAL INDUSTRI — $6.6M (98.6% of Yemen's total)
Key Insight: Yemen's per-shipment average of $672.6K (3158% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Yemen is a key market for Carvedilol imports from India.
4Chile
Chile ranks as the fourth-largest destination for Carvedilol imports from India, with a total trade value of $2.0M across 11 shipments — representing a 2.0% share of all Carvedilol exports. The average shipment value of $181.0K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carvedilol importers in Chile: DIFEM LABORATORIOS S.A, is the largest buyer, accounting for 46.9% ($933.6K) of this market's total imports.
• DIFEM LABORATORIOS S.A, — $933.6K (46.9% of Chile's total)
Key Insight: Chile's per-shipment average of $181.0K (777% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chile is a key market for Carvedilol imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Carvedilol imports from India, with a total trade value of $1.9M across 13 shipments — representing a 2.0% share of all Carvedilol exports. The average shipment value of $148.9K is above the global average of $20.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carvedilol importers in Philippines: OLLEN PHARMA TRADING INC is the largest buyer, accounting for 47.1% ($911.8K) of this market's total imports.
• OLLEN PHARMA TRADING INC — $911.8K (47.1% of Philippines's total)
Key Insight: Philippines's per-shipment average of $148.9K (621% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Carvedilol imports from India.
People Also Ask — Carvedilol Supplier & Trade Network
Who are the top suppliers of Carvedilol from India?+
Which companies buy Carvedilol from Indian manufacturers?+
Where does Carvedilol exported from India go?+
What is the market share of the top Carvedilol supplier from India?+
What is the average shipment value for Carvedilol exports from India?+
Is Carvedilol manufactured in India and exported globally?+
Which country imports the most Carvedilol from India?+
Who are the buyers of Carvedilol in Ecuador?+
How concentrated is the Carvedilol supplier market in India?+
How do I find verified buyers for Carvedilol in specific countries?+
Carvedilol Trade Network — Key Takeaways
- 1ZYDUS LIFESCIENCES LIMITED is India's dominant Carvedilol exporter with a 20.1% market share and $19.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 242 suppliers collectively account for 56.2% of all tracked Carvedilol exports, with a combined trade value of $98.1M.
- 3United States is the largest destination market, absorbing 60.1% of India's Carvedilol exports ($59.0M). Ecuador (16.5%) and Yemen (6.9%) follow.
- 4With 4.8K total shipments averaging $20.6K each, the Carvedilol export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH, TO THE PURCHASE MANAGER, F.D.E.C.A — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 98 countries
Network value: $98.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carvedilol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carvedilol.
- 2.Flow Mapping: 242 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,750 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 98 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,750 Verified Shipments
242 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists